Annual FCF
-$166.38 M
+$27.45 M+14.16%
December 31, 2023
Summary
- As of February 7, 2025, LYEL annual free cash flow is -$166.38 million, with the most recent change of +$27.45 million (+14.16%) on December 31, 2023.
- During the last 3 years, LYEL annual FCF has risen by +$45.98 million (+21.65%).
- LYEL annual FCF is now -810.21% below its all-time high of $23.43 million, reached on December 31, 2019.
Performance
LYEL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$35.10 M
+$3.32 M+8.65%
September 30, 2024
Summary
- As of February 7, 2025, LYEL quarterly free cash flow is -$35.10 million, with the most recent change of +$3.32 million (+8.65%) on September 30, 2024.
- Over the past year, LYEL quarterly FCF has increased by +$5.56 million (+13.67%).
- LYEL quarterly FCF is now -15.19% below its all-time high of -$30.47 million, reached on March 31, 2020.
Performance
LYEL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$156.23 M
+$2.78 M+1.75%
September 30, 2024
Summary
- As of February 7, 2025, LYEL TTM free cash flow is -$156.23 million, with the most recent change of +$2.78 million (+1.75%) on September 30, 2024.
- Over the past year, LYEL TTM FCF has increased by +$10.15 million (+6.10%).
- LYEL TTM FCF is now -412.69% below its all-time high of -$30.47 million, reached on March 31, 2020.
Performance
LYEL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
LYEL Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.2% | +13.7% | +6.1% |
| 3 y3 years | +21.6% | +19.3% | +18.5% |
| 5 y5 years | -810.2% | +39.9% | +20.7% |
LYEL Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +14.2% | at high | +39.0% | at high | +20.5% |
| 5 y | 5-year | -810.2% | +21.6% | -15.2% | +63.4% | -412.7% | +33.4% |
| alltime | all time | -810.2% | +21.6% | -15.2% | +63.4% | -412.7% | +33.4% |
Lyell Immunopharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$35.10 M(-8.7%) | -$156.23 M(-1.7%) |
| Jun 2024 | - | -$38.42 M(-8.6%) | -$159.01 M(-1.0%) |
| Mar 2024 | - | -$42.05 M(+3.4%) | -$160.68 M(-3.4%) |
| Dec 2023 | -$166.38 M(-14.2%) | -$40.66 M(+7.3%) | -$166.38 M(-2.5%) |
| Sep 2023 | - | -$37.88 M(-5.5%) | -$170.57 M(-1.2%) |
| Jun 2023 | - | -$40.09 M(-16.0%) | -$172.58 M(-6.2%) |
| Mar 2023 | - | -$47.74 M(+6.5%) | -$183.99 M(-5.1%) |
| Dec 2022 | -$193.83 M | -$44.85 M(+12.4%) | -$193.83 M(+0.7%) |
| Sep 2022 | - | -$39.89 M(-22.5%) | -$192.46 M(+1.5%) |
| Jun 2022 | - | -$51.50 M(-10.6%) | -$189.66 M(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$57.59 M(+32.4%) | -$196.55 M(+2.5%) |
| Dec 2021 | -$191.75 M(-9.7%) | -$43.48 M(+17.2%) | -$191.75 M(-4.1%) |
| Sep 2021 | - | -$37.09 M(-36.5%) | -$199.88 M(+1.4%) |
| Jun 2021 | - | -$58.39 M(+10.6%) | -$197.06 M(-16.0%) |
| Mar 2021 | - | -$52.79 M(+2.3%) | -$234.67 M(+10.5%) |
| Dec 2020 | -$212.35 M(-1006.5%) | - | - |
| Dec 2020 | - | -$51.61 M(+50.6%) | -$212.35 M(+32.1%) |
| Sep 2020 | - | -$34.27 M(-64.3%) | -$160.74 M(+27.1%) |
| Jun 2020 | - | -$96.00 M(+215.0%) | -$126.47 M(+315.0%) |
| Mar 2020 | - | -$30.47 M | -$30.47 M |
| Dec 2019 | $23.43 M | - | - |
FAQ
- What is Lyell Immunopharma annual free cash flow?
- What is the all time high annual FCF for Lyell Immunopharma?
- What is Lyell Immunopharma annual FCF year-on-year change?
- What is Lyell Immunopharma quarterly free cash flow?
- What is the all time high quarterly FCF for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly FCF year-on-year change?
- What is Lyell Immunopharma TTM free cash flow?
- What is the all time high TTM FCF for Lyell Immunopharma?
- What is Lyell Immunopharma TTM FCF year-on-year change?
What is Lyell Immunopharma annual free cash flow?
The current annual FCF of LYEL is -$166.38 M
What is the all time high annual FCF for Lyell Immunopharma?
Lyell Immunopharma all-time high annual free cash flow is $23.43 M
What is Lyell Immunopharma annual FCF year-on-year change?
Over the past year, LYEL annual free cash flow has changed by +$27.45 M (+14.16%)
What is Lyell Immunopharma quarterly free cash flow?
The current quarterly FCF of LYEL is -$35.10 M
What is the all time high quarterly FCF for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly free cash flow is -$30.47 M
What is Lyell Immunopharma quarterly FCF year-on-year change?
Over the past year, LYEL quarterly free cash flow has changed by +$5.56 M (+13.67%)
What is Lyell Immunopharma TTM free cash flow?
The current TTM FCF of LYEL is -$156.23 M
What is the all time high TTM FCF for Lyell Immunopharma?
Lyell Immunopharma all-time high TTM free cash flow is -$30.47 M
What is Lyell Immunopharma TTM FCF year-on-year change?
Over the past year, LYEL TTM free cash flow has changed by +$10.15 M (+6.10%)